Search PubMed⌕ Search

Biomedical subjects

T Tokuyama

Publications and source records attributed to T Tokuyama.

At least 91 records · Page 5Linked to original sources
PubMed1990

[Three orthodontic cases with temporomandibular joint sounds].

Three orthodontically treated cases with sounds of the temporomandibular joint are presented. Case 1: Eight months after [formula: see text] extraction, bilateral TMJ sounds were noticed. The patient had a history of pre-orthodontic TMJ sounds and locking. A disc recapturing splint was therefore set on the upper arch, then changed into a stabilization splint for 5 months. The TMJ sounds faded away and the active treatment was completed. Case 2: The patient had [formula: see text] missing teeth, severe deep bite, upper and lower spaced arches. She also had mild facial deformity and bilateral TMJ sounds. TMJ arthroscopy showed right side "Anterior disk displacement without reduction" and left side "Anterior disk displacement with reduction". Maxillary spaces were closed following standard splint therapy. Right side TMJ sound diminished considerably while left side sound faded away completely. Finally, prosthodontic treatment was performed. Case 3: The patient had mandibular right side shifting, upper and lower crowding and a right side TMJ sound. Initially, maxillary lateral expansion was performed using a Quad-helix appliance. Simultaneously a positioner-type splint was used on the lower arch for avoiding any occlusal interference. TMJ sound faded away and a standard [formula: see text] extraction treatment was completed for crowding correction and better occlusion.

Female↗
PubMed1989

[A case of measles in adolescents with myocarditis and pneumonia].

A 18-year-old man was admitted with fever, dry cough, erythema, conjunctivitis, and dyspnea. The case was diagnosed as measles because of the typical clinical course and the increase of measles viral antibody titre. Electrocardiogram showed transient ST-T abnormalities and the laboratory data showed transient increase of CPK. Therefore myocarditis was considered. However chest roentgenogram showed no abnormal findings. Arterial oxygen was low. The Ga scintigram revealed diffused uptake in both lungs. Microscopic examination of the transbronchial lung biopsy revealed alveolitis. In view of he above, measles pneumonia was diagnosed in this case.

Adolescent↗
PubMed1988

Iodide-induced thyrotoxicosis in a thyroidectomized patient with metastatic thyroid carcinoma.

An unusual case of iodide-induced thyrotoxicosis is documented in this article. The patient was a 64-year-old euthyroid man with acromegaly. He also had multiple follicular and papillary thyroid carcinomas with a metastatic lesion in the lumbar vertebrae. After a total thyroidectomy, he became slightly hypothyroid, and the lumbar lesion began to incorporate 131I by scintigraphy. When an iodine-containing contrast medium happened to be injected, a transient increase of serum thyroid hormone level was observed. After complete thyroid ablation with 83 mCi of 131I, the oral administration of 100 mg of potassium iodide for 7 days induced a prominent increase of serum thyroid hormone level. These findings indicated that the metastatic thyroid carcinoma could produce excess thyroid hormone insofar as a sufficient amount of iodide was given. Although this is the first report of such a case, iodide-induced thyrotoxicosis may not be rare in patients with thyroid carcinomas because the Wolff-Chaikoff effect is thought to be lost, and the organic iodinating activity and lysosomal protease activity are well-preserved.

Acromegaly↗
PubMed1988

[The findings of auditory and somatosensory evoked potentials in brain death confirmed by the apnea test].

The findings of AEP and SEP in the cases with brain death confirmed by the apnea test had not been reported. We studied the features and the characteristic changes of those evoked potentials in 7 cases of brain death. The etiology of brain death in those cases were the primary intracranial lesions in six and the brain ischemia secondary to cardiac arrest in the others. The apnea test and the recordings of AEP and SEP were performed in the same day in most cases. The mean intervals from the application of the respirator to the apnea test and to cardiac arrest were 5.8 +/- 7.1 days and 5.9 +/- 7.2 days, respectively. Cardiac arrest occurred with mean of 11.8 +/- 8.0 days after the application of the respirator. AEP showed absent responses in six cases (86%) and wave I only in the other (14%). SEP showed P 1-N 1 in four cases (57%) and no responses in three (43%). The components of AEP were disturbed earlier than those of SEP and cases were classified into three types according to those findings. Type I (one case, 13%): wave I only in AEP and P 1-N 1 in SEP. Type II (three cases, 28%): no wave in AEP and P 1-N 1 in SEP. Type III (three cases, 28%): no wave in AEP and SEP.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1987

Digestion of thyroglobulin with purified thyroid lysosomes: preferential release of iodoamino acids.

[131I]Thyroglobulin [( 131I]Tg), prepared by either enzymatic iodination of human goiter Tg in vitro or isolation from the thyroids of rats previously injected with 131I, was digested with a solubilized enzyme mixture prepared from purified hog thyroid lysosomes. The digestion was performed at 37 C for 24 h under nitrogen at pH 5.0 in the presence of 4 mM dithiothreitol. Under these conditions the release of free [131I] iodoamino acids (MIT, DIT, T4, and T3) was quantitatively very similar to that observed with a standard pronase digestion procedure. To determine whether other amino acids in Tg were released as quantitatively as the iodoamino acids, free amino acids in the lysosomal digest were measured, and total free amino acid release was compared with a similar analysis performed after digestion of [131I]Tg with 6 N HCl. Total amino acid release was much less complete than iodoamino acid release, indicating preferential release of iodoamino acids from Tg by lysosomal digestion. Analysis of the lysosomal digest by HPLC on a size exclusion column indicated that Tg was degraded to peptides with a mol wt less than 4000. Assuming that the in vitro lysosomal digestion system represents a valid model for the physiological proteolytic system that degrades Tg, the results of the present study suggest that a substantial portion of the Tg in the thyroid is not degraded to free amino acids and that peptide fragments of Tg are normally present in the thyroid. In such a case, the fate and possible physiological activity of these fragments require further elucidation.

Amino Acids↗
PubMed1983

Clinical importance of reversibility in primary goitrous hypothyroidism.

Twenty seven hypothyroid patients with a serum concentration of thyroid stimulating hormone (TSH) of over 40 mU/1 were followed up for three to 20 weeks without replacement therapy. The serum thyroid hormone concentrations increased with a dramatic decrease in serum TSH values in 14 patients (reversible group) but there was no significant change in the other 13 (irreversible group). Fourteen out of 19 patients with goitre but none of the eight patients without goitre belonged to the reversible group. All of the 11 patients with a high uptake of iodide by the thyroid, three of the six with a normal uptake, and none of the 10 with a low uptake belonged to the reversible group. These observations indicate that patients with goitrous hypothyroidism with a preserved thyroid uptake of iodide are likely to become euthyroid spontaneously without replacement therapy.

Adult↗
PubMed1983

Picomole analyses of tryptophan by derivatization to 9-hydroxymethyl-beta-carboline.

A new method specific for the determination of subpicomole quantities of tryptophan has been developed by elaboration of the Pictet-Spengler reaction. It permitted reproducible quantitation of tryptophan in less than 1 microliter of plasma ultrafiltrate or 1 mg of brain tissue. Samples deproteinized by trichloroacetic acid were boiled for 15 min with formaldehyde and potassium ferricyanide at controlled acidity, where tryptophan was converted to a single new product identified as 9-hydroxymethyl-beta-carboline. It was quantitated by either direct spectrofluorometry or a reversed-phase HPLC system developed for beta-carbolines. Under our conditions, peptides containing N-terminal tryptophan such as Trp-Leu and delta sleep-inducing peptide gave N-(9-hydroxymethyl-beta-carboline-3-carbonyl) peptides which retained all amino acid residues except tryptophan.

Animals↗
PubMed1982

A cyclohexanecarboxylic acid utilizing yeast: isolation, identification, and nutritional characteristics.

A yeast capable of utilizing cyclohexanecarboxylic acid as sole carbon and energy source, strain KUY-6A, was isolated from soil by enrichment cultures. Taxonomical studies indicated that strain KUY-6A was Trichosporon cutaneum. Strain KUY-6A grew on a number of carboxylic acids. Among the cyclic compounds tested, cyclohexanecarboxylic acid was the best substrate. Cyclopentanecarboxylic acid, cycloheptanecarboxylic acid, cyclopentanone, cyclohexanone, and cyclopentanol also supported growth. In addition, the organism used the monocarboxylic acids, butyric, valeric, and caproic; the dicarboxylic acids succinic, glutaric, adipic, pimelic, and suberic; and the aromatic acids, benzoic and o-, m-, and p-hydroxybenzoic. The yeast did not require any vitamins for growth, although thiamine gave slight stimulation. The cell dry weight yield was 0.75 g from 1 g cyclohexanecarboxylic acid used.

Cyclohexanecarboxylic Acids↗
PubMed1982

Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.

Various histrionicotoxins tested on frog nerve-muscle preparations showed a qualitative family resemblance to one another. They blocked the nerve-evoked muscle twitch and depressed both the peak amplitudes and the decay time constants of end-plate currents. During repetitive stimulation they progressively decreased the rate of rise and prolonged the falling phase of muscle action potentials, the latter resulting, at least in part, from blockade of voltage-sensitive potassium channels. These results indicated that the histrionicotoxins act at three membrane channels: the channel associated with the acetylcholine receptor, the sodium channel, and the potassium channel. Closer study of perhydrohistrionicotoxin suggested either two topographically distinct sites of action at the acetylcholine receptor-ion channel complex, or one site and two ion channel complex conformations. One site or conformation only alters the kinetics of channel closure. As these sites become saturated, the end-plate current decay time constant asymptotically approaches a limiting value. The other site or conformation prevents the channel from opening altogether. Further analysis indicated that the binding site for perhydrohistrionicotoxin that alters the kinetics of channel closure has an affinity constant of 0.1 microM-1 at -90 mV and that this affinity may be sensitive to the membrane potential. The lipid protein interface is a suggested site of histrionicotoxin action, common to the three channels studied here as well as to other intrinsic membrane proteins affected by histrionicotoxins.

Action Potentials↗
PubMed1981

Enzymatic modification of tryptophan residues by tryptophan side chain oxidase I and II from Pseudomonas.

The enzymatic modification of tryptophan residues in Trp-Leu, Leu-Trp, Leu-Trp-Leu, and yeast mating hormone (alpha-factor), a tridecapeptide containing Trp-1 and Trp-3, has been investigated with tryptophan side chain oxidase I crystallized previously from Pseudomonas and tryptophan side chain oxidase II recently isolated from the same organism. With Trp-Leu as substrate, threo- and erythro-beta-hydroxytryptophan residues were identified as primary products and the former perferentially underwent second step dehydrogenation to give beta-ketotryptophan. Free threo- and erythro-beta-hydroxytryptophan, hitherto undescribed tryptophan derivatives, were isolated after enzymatic hydrolysis, identified, and characterized. Leu-alpha, beta-dehydrotryptamine, a new biochemical entity, was a sole main product of Leu-Trp. With Leu-Trp-Leu, diastereoisomeric Leu-beta-hydroxyl-Trp-Leu and Leu-alpha, beta-dehydro-Trp-Leu were formed simultaneously, the pH and ionic strength being determinants of the ratio of these products. Leu-threo-beta-hydroxy-Trp-Leu was also converted to Leu-beta-keto-Trp-Leu, but, distinct from NH2-terminal beta-hydroxytryptophan, both diastereoisomers underwent acid-catalyzed dehydration to give Leu-alpha, beta-dehydro-Trp-Leu. Thus, the mode of modification was shown to be prescribed by the site of tryptophan in peptides and the results were the same with either tryptophan side chain oxidase I or II, except that the latter was almost inactive on Trp-Leu. With any substrate, 3-indolecarboxaldehyde was a sole detectable by-product.

Magnetic Resonance Spectroscopy↗
PubMed1979

Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine.

In order to clarify the role of indoleamine 2,3-dioxygenase [indole:oxygen 2,3-oxidoreductase (decyclizing), EC 1.13.11.17] in the metabolism of serotonin, DL-5-hydroxy[methylene-(14)C]tryptophan, a precursor of serotonin, was incubated with slices of rabbit ileum. Resulting metabolites were separated by DEAE-cellulose column and polyamide column chromatography and identified by various chromatographic techniques and enzymatic analysis. Metabolites obtained in significant amounts were serotonin, 5-hydroxyindoleacetic acid, 5-hydroxytryptophol, 5-hydroxykynurenine, 5-hydroxykynurenamine, and 4,6-dihydroxyquinoline, representing 13.2, 15.8, 7.0, 21.9, 1.3, and 2.6% of the total metabolites, respectively. The first three compounds were previously reported to be major metabolites produced from 5-hydroxytryptophan by the action of aromatic L-amino acid decarboxylase and monoamine oxidase, whereas the last three are formed by the cleavage of the indole ring by the action of indoleamine 2,3-dioxygenase. In the presence of pargyline, a monoamine oxidase inhibitor, the major metabolites obtained were serotonin, 5-hydroxykynurenine, and 5-hydroxykynurenamine, representing 29.6, 26.6, and 5.4% of the total metabolites, respectively. In the presence of RO4-4602, an aromatic amino acid decarboxylase inhibitor, 5-hydroxykynurenine was the sole major product. These results strongly suggest that the newly discovered metabolic pathway involving the cleavage of the indole ring of 5-hydroxytryptophan operates in vivo to a significant extent and that indoleamine 2,3-dioxygenase plays an important role in the regulation of serotonin levels in the small intestine of the rabbit.

5-Hydroxytryptophan↗
PubMed1978

Effects of indoleamines and their newly identified metabolites on prolactin release in rats.

Plasma immunoreactive PRL responses to indoleamines and their metabolites were studied in urethane-anesthetized rats. All drugs were injected into the lateral ventricle and blood samples were serially collected from a jugular vein. Serotonin and melatonin caused a significant increase in plasma PRL with peak values at 10-20 min after the injection. Significant increase in plasma PRL were also observed after the administration of 5-hydroxykynurenamine (5-HK), a newly identified serotonin metabolite. The potency of 5-HK was less than that of serotonin but much greater than that of melatonin. In contrast, plasma PRL did not change significantly in response to N-acetyl-5-methoxykynurenamine, another newly identified metabolite of melatonin, or a vehicle solution. Simultaneous administration of melatonin significantly blunted the plasma PRL response to serotonin, whereas the rise in plasma PRL induced by 5-HK was not blunted by melatonin. These results suggest that indoleamines as well as their metabolites play a role in regulating PRL secretion in rats.

5-Hydroxytryptophan↗